In order to identify further low-risk susceptibility loci, it will be necessary to look at specific morphological subtypes including DCIS and the cytonuclear grade and estrogen receptor (ER) status of the disease. The gene discussed is ESR1; the disease is ductal breast carcinoma in situ.